Evidence map›Paper›PMID 39867432›Full record

ArticleFrontiers in allergy2024

Assessment of information quality in the largest Danish Facebook group on atopic diseases: a mixed bag of help and harm.

Simon Høj, Simon Francis Thomsen, Hanieh Meteran, Torben Sigsgaard, Howraman Meteran

Abstract read
In one paragraph

Article in Frontiers in allergy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Simon HøjDepartment of Dermatology, Venereology, and Wound Healing Centre, Copenhagen University Hospital-Bispebjerg, Copenhagen, Denmark.
Simon Francis ThomsenDepartment of Dermatology, Venereology, and Wound Healing Centre, Copenhagen University Hospital-Bispebjerg, Copenhagen, Denmark.
Hanieh MeteranDepartment of Endocrinology, Copenhagen University Hospital-Hvidovre, Hvidovre, Denmark.
Torben SigsgaardDepartment of Public Health, Environment, Occupation, and Health, Aarhus University, Aarhus, Denmark.
Howraman MeteranDepartment of Public Health, Environment, Occupation, and Health, Aarhus University, Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patient education is an important part of the management of atopic diseases such as allergic rhinitis, atopic dermatitis, and asthma. Given the increasing reliance on social media platforms such as Facebook for health-related discourse, there are concerns about the accuracy and quality of the shared information. Aim: The aim of this study was to categorize and assess the quality of the information shared within the largest Danish Facebook group focusing on atopic diseases. Method: A total of 652 posts and 7,515 comments were scrutinized, classifying each as useful, misleading, or neutral. Results: The analysis predominantly identified discussions around asthma (40%), allergic rhinitis (21%), and eczema (5%), with the majority of queries posed by women and related to symptoms and medications. The results indicated that 11% of comments were deemed useful, whereas 12% were categorized as misleading, with the bulk of comments being neutral. Concerningly, 52% of the comments promoting behavioral change were found to be misleading. Conclusion: Although the Facebook group serves as a hub for peer support, its utility as a reliable educational resource is compromised. Overall, 12% of the comments were classified as misleading, while more than half of the advice encouraging behavioral change was misleading.

Indexed as

asthmaatopic diseasesdermatitisrhinitissocial media

Identifiers

PMID39867432
PMCPMC11757893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.